A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
Journal of Neuro-Oncology · 2025
DOI: 10.1007/s11060-024-04852-7 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Ethan A Wetzel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Brain Neoplasms, Mutation, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NINDS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.
- Department of Neurosurgery, Medical Faculty, Heidelberg University, Heidelberg, Germany.
- Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
- Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
Förderung
- NINDS NIH HHS
- NINDS
Zitieren
APA
Wetzel, E. A., Nohman, A. I., Hsieh, A. L., Reuss, D., Unterberg, A. W., Eyüpoglu, I. Y., Hua, L., Youssef, G., Wen, P. Y., Cahill, D. P., Jungk, C., Juratli, T. A., & Miller, J. J. (2025). A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04852-7
Vancouver
Wetzel EA, Nohman AI, Hsieh AL, Reuss D, Unterberg AW, Eyüpoglu IY, et al. A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-024-04852-7
BibTeX
@article{Wetzel2025,
author = {Wetzel, Ethan A and Nohman, Amin I and Hsieh, Annie L and Reuss, David and Unterberg, Andreas W and Eyüpoglu, Ilker Y and Hua, Lingyang and Youssef, Gilbert and Wen, Patrick Y and Cahill, Daniel P and Jungk, Christine and Juratli, Tareq A and Miller, Julie J},
title = {A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design},
journal = {Journal of Neuro-Oncology},
year = {2025},
doi = {10.1007/s11060-024-04852-7}
}
EUVIMED